Released: May 25, 2017
售不合格非處方藥 嬌生賠款3300萬
Source: World Journal Newspaper
醫護產品巨擘嬌生公司(Johnson & Johnson)24日與42個州就被控生產、出售未達聯邦品質標準的非處方藥達成和解，賠償3300萬元。
Read Full Article: Johnson & Johnson selling sub-standard non-prescriptive drugs (Chinese)
Quick Menu
